BOUDREAUX GAIL 4
4 · Elevance Health, Inc. · Filed Jul 23, 2024
Insider Transaction Report
Form 4
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-07-22$501.40/sh−6,621$3,319,769→ 132,209 total - Sale
Common Stock
2024-07-22$503.67/sh−1,000$503,670→ 128,959 total - Sale
Common Stock
2024-07-22$502.23/sh−2,250$1,130,018→ 129,959 total - Sale
Common Stock
2024-07-22$504.27/sh−2,250$1,134,608→ 126,709 total - Sale
Common Stock
2024-07-22$498.50/sh−1,100$548,350→ 159,609 total - Sale
Common Stock
2024-07-22$500.36/sh−20,779$10,396,980→ 138,830 total
Holdings
- 60(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $499.82 to $500.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $500.83 to $501.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $501.96 to $502.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $503.05 to $503.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $504.1 to $504.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.